Immunologic lung diseases (Part 2)

Herbert Reynolds

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

This review has traced some of the factors that have contributed to the current enthusiasm about lung immunology and will continue by illustrating this interest with examples of lung disease that have received particular investigation recently. Our disease classification is based on probable immune mechanisms that occur in the lungs, acknowledged to be an insufficient framework to account for all the complex interactions that undoubtedly exist in diseased lungs, but still a useful scheme for general organization of important concepts. Examples of types 1 and 2 immunologic diseases have been presented and others will be given for types 3 and 4 mechanisms. Afterward, an attempt to address the clinical relevance of new immunologic concepts will be offered.

Original languageEnglish (US)
Pages (from-to)745-751
Number of pages7
JournalChest
Volume81
Issue number6
DOIs
StatePublished - Jan 1 1982

Fingerprint

Immune System Diseases
Lung Diseases
Lung
Allergy and Immunology

All Science Journal Classification (ASJC) codes

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Reynolds, Herbert. / Immunologic lung diseases (Part 2). In: Chest. 1982 ; Vol. 81, No. 6. pp. 745-751.
@article{3084f217e2174a80bf281cb22dd298ef,
title = "Immunologic lung diseases (Part 2)",
abstract = "This review has traced some of the factors that have contributed to the current enthusiasm about lung immunology and will continue by illustrating this interest with examples of lung disease that have received particular investigation recently. Our disease classification is based on probable immune mechanisms that occur in the lungs, acknowledged to be an insufficient framework to account for all the complex interactions that undoubtedly exist in diseased lungs, but still a useful scheme for general organization of important concepts. Examples of types 1 and 2 immunologic diseases have been presented and others will be given for types 3 and 4 mechanisms. Afterward, an attempt to address the clinical relevance of new immunologic concepts will be offered.",
author = "Herbert Reynolds",
year = "1982",
month = "1",
day = "1",
doi = "10.1016/S0012-3692(16)57764-2",
language = "English (US)",
volume = "81",
pages = "745--751",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "6",

}

Immunologic lung diseases (Part 2). / Reynolds, Herbert.

In: Chest, Vol. 81, No. 6, 01.01.1982, p. 745-751.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Immunologic lung diseases (Part 2)

AU - Reynolds, Herbert

PY - 1982/1/1

Y1 - 1982/1/1

N2 - This review has traced some of the factors that have contributed to the current enthusiasm about lung immunology and will continue by illustrating this interest with examples of lung disease that have received particular investigation recently. Our disease classification is based on probable immune mechanisms that occur in the lungs, acknowledged to be an insufficient framework to account for all the complex interactions that undoubtedly exist in diseased lungs, but still a useful scheme for general organization of important concepts. Examples of types 1 and 2 immunologic diseases have been presented and others will be given for types 3 and 4 mechanisms. Afterward, an attempt to address the clinical relevance of new immunologic concepts will be offered.

AB - This review has traced some of the factors that have contributed to the current enthusiasm about lung immunology and will continue by illustrating this interest with examples of lung disease that have received particular investigation recently. Our disease classification is based on probable immune mechanisms that occur in the lungs, acknowledged to be an insufficient framework to account for all the complex interactions that undoubtedly exist in diseased lungs, but still a useful scheme for general organization of important concepts. Examples of types 1 and 2 immunologic diseases have been presented and others will be given for types 3 and 4 mechanisms. Afterward, an attempt to address the clinical relevance of new immunologic concepts will be offered.

UR - http://www.scopus.com/inward/record.url?scp=0020001296&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020001296&partnerID=8YFLogxK

U2 - 10.1016/S0012-3692(16)57764-2

DO - 10.1016/S0012-3692(16)57764-2

M3 - Article

C2 - 6978800

AN - SCOPUS:0020001296

VL - 81

SP - 745

EP - 751

JO - Chest

JF - Chest

SN - 0012-3692

IS - 6

ER -